Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease

Autor: Kevin Taddei, Michael W. Weiner, Belinda M. Brown, Hamid R. Sohrabi, Jeremiah J. Peiffer, Colin L. Masters, Chengjie Xiong, Tammie L.S. Benzinger, Neill R. Graff-Radford, Christoph Laske, Peter R. Schofield, Virginia Buckles, Stephanie R. Rainey-Smith, James M. Noble, Jonathan Vöglein, Roger Clarnette, Anne M. Fagan, Martin N. Rossor, Ralph N. Martins, Samantha L. Gardener, Stephen Salloway, Nigel J. Cairns, John C. Morris, Randall J. Bateman, Tejal M. Shah, Kirk I. Erickson
Rok vydání: 2017
Předmět:
0301 basic medicine
Male
Pathology
Aging
Epidemiology
2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
genetics [Alzheimer Disease]
Disease
cerebrospinal fluid [Amyloid beta-Peptides]
Neurodegenerative
Alzheimer's Disease
Cohort Studies
Amyloid beta-Protein Precursor
0302 clinical medicine
Cerebrospinal fluid
Surveys and Questionnaires
2.1 Biological and endogenous factors
Cognitive decline
Aetiology
Aniline Compounds
biology
Health Policy
Brain
genetics [Presenilin-1]
Middle Aged
amyloid beta-protein (1-42)
Magnetic Resonance Imaging
Psychiatry and Mental health
genetics [Amyloid beta-Protein Precursor]
Neurological
Female
Alzheimer's disease
Psychology
metabolism [Alzheimer Disease]
Adult
medicine.medical_specialty
Amyloid
Genotype
Amyloid beta
Clinical Sciences
genetics [Mutation]
genetics [Presenilin-2]
tau Proteins
physiopathology [Alzheimer Disease]
Presenilin
Article
03 medical and health sciences
Cellular and Molecular Neuroscience
PSEN1 protein
human

Apolipoproteins E
Developmental Neuroscience
Alzheimer Disease
Internal medicine
mental disorders
Presenilin-2
medicine
Presenilin-1
Genetics
Acquired Cognitive Impairment
Dementia
Humans
ddc:610
cerebrospinal fluid [Peptide Fragments]
diagnostic imaging [Brain]
Exercise
metabolism [Amyloid]
Amyloid beta-Peptides
PSEN2 protein
human

Physical activity
Neurosciences
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Amyloid β
medicine.disease
Peptide Fragments
Brain Disorders
Thiazoles
030104 developmental biology
Endocrinology
Cross-Sectional Studies
cerebrospinal fluid [tau Proteins]
metabolism [Brain]
Geriatrics
Positron-Emission Tomography
Dominantly Inherited Alzheimer Network
Mutation
biology.protein
Linear Models
genetics [Apolipoproteins E]
Neurology (clinical)
Geriatrics and Gerontology
Tau
diagnostic imaging [Alzheimer Disease]
physiology [Exercise]
030217 neurology & neurosurgery
Zdroj: Alzheimer's & dementia : the journal of the Alzheimer's Association, vol 13, iss 11
Alzheimer's and dementia 13(11), 1197-1206 (2017). doi:10.1016/j.jalz.2017.03.008
Popis: Introduction The objective of this study was to evaluate the relationship between self-reported exercise levels and Alzheimer's disease (AD) biomarkers, in a cohort of autosomal dominant AD mutation carriers. Methods In 139 presymptomatic mutation carriers from the Dominantly Inherited Alzheimer Network, the relationship between self-reported exercise levels and brain amyloid load, cerebrospinal fluid (CSF) Aβ 42, and CSF tau levels was evaluated using linear regression. Results No differences in brain amyloid load, CSF Aβ 42 , or CSF tau were observed between low and high exercise groups. Nevertheless, when examining only those already accumulating AD pathology (i.e., amyloid positive), low exercisers had higher mean levels of brain amyloid than high exercisers. Furthermore, the interaction between exercise and estimated years from expected symptom onset was a significant predictor of brain amyloid levels. Discussion Our findings indicate a relationship exists between self-reported exercise levels and brain amyloid in autosomal dominant AD mutation carriers.
Databáze: OpenAIRE